MorphoSys intends to use the issue proceeds to further expand the Company’s research antibody segment, operating under the brand Antibodies Direct, and accelerate external and internal sales growth of the unit.
MorphoSys intends to use the issue proceeds to further expand the Company’s research antibody segment, operating under the brand Antibodies Direct, and accelerate external and internal sales growth of the unit.